In a landmark legal ruling, Jasveen Sangha — widely dubbed the "Ketamine Queen" — was sentenced to 15 years in federal prison after pleading guilty to distributing the drug that contributed to the death of beloved Friends star Matthew Perry in 2023. The sentencing brings a measure of justice to a case that shocked Hollywood and prompted broader conversations about celebrity addiction and drug supply networks.
The Matthew Perry Case
Matthew Perry, who played the iconic Chandler Bing on Friends for a decade, passed away in October 2023 from acute ketamine effects. Investigations revealed that he had been receiving large quantities of ketamine through a network of suppliers, with Sangha identified as a key distributor who provided the drug knowing it was being used recreationally and at dangerous doses.
The Legal Battle
Sangha's case was one of several prosecutions connected to Perry's death. Prosecutors argued she was aware of the risks and continued to supply the drug for financial gain. Her guilty plea and subsequent 15-year sentence reflect the severity of her role in enabling Perry's fatal overdose.
A Wake-Up Call on Celebrity Drug Culture
The Perry case has intensified scrutiny on ketamine use in Hollywood and the networks that supply it. Mental health advocates are calling for greater regulation of ketamine clinics and stricter oversight of controlled substance distribution.
Matthew Perry's legacy as a brilliant comedian and advocate for addiction recovery continues to resonate, and this sentencing ensures his story serves as a warning about the deadly consequences of unregulated drug supply chains.
Read next
Taylor Swift ring | Jean Smart premiere | Steinfeld Allen baby | Dakota Johnson PDA | Baywatch reboot filming | Perry dealer sentenced | Malcolm reboot news | Siwa Hughes anniversary | Gilgo killer plea | Fashion Trust awards
Masters 2026 start | Dodgers rout Jays | Durant beats Suns | Wembanyama injury update | UNC hires Malone | Scheffler baby news | Doncic playoff return | Lopes dies at 80 | Bulls end skid | McIlroy dinner menu
Ceasefire market rally | Intel joins Terafab | Samsung AI surge | ASML shares fall | Broadcom AI deals | FOMC rate divide | AI burn rates | US jobs growth | TSMC US investment | Insurer stocks surge
